𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Suppression of vascular endothelial cell functions by a novel NF-κB inhibitor, DHMEQ

✍ Scribed by K. Umezawa

Book ID
116313722
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
99 KB
Volume
60
Category
Article
ISSN
0753-3322

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting NF-κB and induction of apoptos
Targeting NF-κB and induction of apoptosis by novel NF-κB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) in Burkitt lymphoma cells
✍ Noriko Kimura; Yoshitaka Miyakawa; Kanoko Kohmura; Kazuo Umezawa; Yasuo Ikeda; M 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 401 KB

A new NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), inhibited proliferation and induced apoptosis in human Burkitt lymphoma, HS-Sultan and Daudi cell lines. The activation of caspase-3 and the cleavage of caspase substrate PARP were observed after treatment with DHMEQ. The induction o

A novel NF-κB inhibitor DHMEQ selectivel
A novel NF-κB inhibitor DHMEQ selectively targets constitutive NF-κB activity and induces apoptosis of multiple myeloma cells in vitro and in vivo
✍ Mariko Watanabe; Md. Zahidunnabi Dewan; Takamitu Okamura; Masataka Sasaki; Kinji 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 453 KB

Multiple myeloma (MM) is a fatal lymphoid malignancy that is incurable with conventional modalities of chemotherapy. Strong and constitutive activation of nuclear factor kappa B (NF-kappaB) is a common characteristic of MM cells. In our study we successfully target NF-kappaB with a novel NF-kappaB i